Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 163

1.

Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration.

Shi J, Zhong X, Song Y, Wu Z, Gao P, Zhao J, Sun J, Wang J, Liu J, Wang Z.

Cell Biochem Funct. 2019 Jan;37(1):11-20. doi: 10.1002/cbf.3368. Epub 2018 Nov 30.

PMID:
30499136
2.

Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.

Junge A, Zandi R, Havgaard JH, Gorodkin J, Cowland JB.

Gene. 2017 Jun 5;615:35-40. doi: 10.1016/j.gene.2017.03.015. Epub 2017 Mar 16.

PMID:
28322996
3.
4.

RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells.

Migas AA, Mishkova OA, Ramanouskaya TV, Ilyushonak IM, Aleinikova OV, Grinev VV.

Leuk Res. 2014 Sep;38(9):1102-10. doi: 10.1016/j.leukres.2014.06.002. Epub 2014 Jun 13.

PMID:
24976338
5.

Runx1t1 (Runt-related transcription factor 1; translocated to, 1) epigenetically regulates the proliferation and nitric oxide production of microglia.

Baby N, Li Y, Ling EA, Lu J, Dheen ST.

PLoS One. 2014 Feb 19;9(2):e89326. doi: 10.1371/journal.pone.0089326. eCollection 2014.

6.

Mutational analysis of RUNX1T1 gene in acute leukemias, breast and lung carcinomas.

Kim YR, Kim MS, Lee SH, Yoo NJ.

Leuk Res. 2011 Sep;35(9):e157-8. doi: 10.1016/j.leukres.2011.04.024. Epub 2011 May 14. No abstract available.

PMID:
21571369
7.

RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms.

Nasir A, Helm J, Turner L, Chen DT, Strosberg J, Hafez N, Henderson-Jackson EB, Hodul P, Bui MM, Nasir NA, Hakam A, Malafa MP, Yeatman TJ, Coppola D, Kvols LK.

Pancreas. 2011 May;40(4):627-33. doi: 10.1097/MPA.0b013e3182152bda.

8.

The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.

Ajore R, Dhanda RS, Gullberg U, Olsson I.

BMC Mol Biol. 2010 May 20;11:38. doi: 10.1186/1471-2199-11-38.

9.

NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.

Hackanson B, Abdelkarim M, Jansen JH, L├╝bbert M.

Leukemia. 2010 Apr;24(4):860-1. doi: 10.1038/leu.2009.291. Epub 2010 Jan 21. No abstract available.

PMID:
20090777
10.

Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.

Guo C, Hu Q, Yan C, Zhang J.

Mol Cell Biol. 2009 May;29(10):2644-57. doi: 10.1128/MCB.00073-09. Epub 2009 Mar 16.

11.

[Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype].

Miao YQ, Chen ZX, He J, Cen JN, Bao XJ, Qiu QC, Zhang DE, Yan M.

Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):27-9. Chinese.

PMID:
17649722
12.

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.

Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, Zhang DE.

Nat Med. 2006 Aug;12(8):945-9. Epub 2006 Jul 30.

PMID:
16892037
14.

The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.

Lindberg SR, Olsson A, Persson AM, Olsson I.

Exp Hematol. 2005 Feb;33(2):189-98.

PMID:
15676213
15.

The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells.

Martinez N, Drescher B, Riehle H, Cullmann C, Vornlocher HP, Ganser A, Heil G, Nordheim A, Krauter J, Heidenreich O.

BMC Cancer. 2004 Aug 6;4:44.

16.

Cloning, expression, purification and crystallization of NHR3 domain from acute myelogenous leukemia-related protein AML1-ETO.

Yang HT, Wu DH, Xue XY, Liang WX, Miao XY, Pang H, Chen SJ.

Acta Biochim Biophys Sin (Shanghai). 2004 Aug;36(8):566-70.

PMID:
15295650
17.

[Analysis of 21 children with acute non-lymphoid leukemia carrying AML1/ETO fusion gene].

Zhao W, Li ZG, Wu MY, Geng LZ, Shi HW, Zhang YH, Wu RH.

Zhonghua Er Ke Za Zhi. 2003 May;41(5):325-8. Chinese.

PMID:
14751048
18.

Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.

Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL, van Wijnen AJ, Stein GS.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15434-9. Epub 2002 Nov 11.

19.

Analysis of the nuclear distribution of the translocation t(8;21)-derived fusion protein AML1/ETO by confocal laser scanning microscopy.

Nagel S, Hambach L, Krauter J, Venturini L, Heidenreich O, Ganser A, Heil G.

J Hematother Stem Cell Res. 2002 Apr;11(2):401-8.

PMID:
11983111
20.

Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity.

Ferrara F, Del Vecchio L.

Haematologica. 2002 Mar;87(3):306-19. Review.

Supplemental Content

Support Center